| Autor: |
Castelli, Alessandro, Lanzafame, Massimiliano, Morra, Matteo, Bertoldi, Marco, Delama, Andrea, Fait, Daniela, Vento, Sandro |
| Zdroj: |
AIDS Research & Human Retroviruses; May2024, Vol. 40 Issue 5, p283-285, 3p |
| Abstrakt: |
The availability of long-acting cabotegravir and rilpivirine injection combination requires some changes in service delivery of outpatient HIV clinics; it is therefore important for clinicians to know the potential number of people living with HIV (PLWH) who are interested in a long-acting antiretroviral treatment. We aimed to determine in an outpatient clinic the number of PLWH, on dolutegravir/rilpivirine, accepting a switch to an injectable long-acting antiretroviral treatment, and the reasons underlying this choice. In our single-center study, in this subset of HIV-infected patients, the main cause for refusal of a long-acting injectable regimen was the need for the administration to be done in hospital, as required in Italy, suggesting that current regulations about this aspect must be changed. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
